Engagement of natural cytotoxicity programs regulates AP-1 expression in the NKL human NK cell line

Journal of Immunology

Volumn 162, Issue 7, 1999, Pages 4062-4068

  Bernard, Karine ^a   Cambiaggi, Anna ^b   Guia, Sophie ^a   Bertucci, François ^d   Granjeaud, Samuel ^a   Tagett, Rebecca ^a   N'Guyen, Catherine ^a   Jordan, Bertrand R ^a   Vivier, Eric ^a,c,e  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c INSTITUT UNIVERSITAIRE DE FRANCE   (France)

^d INSTITUT PAOLI CALMETTES   (France)

^e CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; IMMUNOGLOBULIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DNA BINDING; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; TARGET CELL;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DNA; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; NUCLEIC ACID HYBRIDIZATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

EID: 0033120113     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Kägi, D., B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
2. Robertson, M. J., and J. Ritz. 1990. Biology and clinical relevance of human natural killer cells. Blood 76:2421.
3. Lanier, L. L., and J. H. Philips. 1992. Natural killer cells. Curr. Opin. Immunol. 4:38.
4. Oliva, A., A. L. Kinter, M. Vaccarezza, A. Rubbert, A. Catanzaro, S. Moir, J. Monaco, L. Ehler, S. Mizell, R. Jackson, Y. Li, J. W. Romano, and A. S. Fauci. 1998. Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. J. Clin. Invest. 102:223.
5. Asai, O., D. L. Longo, Z. G. Tian, R. L. Hornung, D. D. Taub, F. W. Ruscetti, and W. J. Murphy. 1998. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. J. Clin. Invest. 101:1835.
6. Mehrotra, P. T., R. P. Donnelly, S. Wong, H. Kanegane, A. Geremew, H. S. Mostowski, K. Furuke, J. P. Siegel, and E. T. Bloom. 1998. Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J. Immunol. 160:2637.
7. Moretta, A., and L. Moretta. 1997. HLA class I specific inhibitory receptors. Curr. Opin. Immunol. 9:694.
8. Lanier, L. L. 1998. NK Cell Receptors. Annu. Rev. Immunol. 16:359.
9. Long, E. O., and N. Wagtmann. 1997. Natural killer cell receptors. Curr. Opin. Immunol. 9:344.
10. Burshtyn, D. N., and E. O. Long. 1997. Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell. Biol. 7:473.
11. Vivier, E., and M. Daëron. 1997. Immunoreceptor tyrosine-based inhibition motifs (ITIMs). Immunol. Today 18:286.
12. Binstadt, B. A., K. M. Brumbaugh, and P. J. Leibson. 1997. Signal transduction by human NK cell MHC-recognizing receptors. Immunol. Rev. 155:197.
13. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J.-P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4:77.
14. Olcese, L., P. Lang, F. Vély, A. Cambiaggi, D. Marguet, M. Blery, K. L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J. C. Cambier, and E. Vivier. 1996. Human and mouse killer cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156:4531.
15. Binstadt, B. A., K. M. Brumbaugh, C. J. Dick, A. M. Scharenberg, B. L. Williams, M. Colonna, L. L. Lanier, J.-P. Kinet, R. T. Abraham, and P. J. Leibson. 1996. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation. Immunity 5:629.
16. Leibson, P. J. 1997. Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655.
17. Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J. V. Ravetch. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90:293.
18. Sivori, S., M. Vitale, L. Morelli, L. Sanseverino, R. Augugliaro, C. Bottino, L. Moretta, and A. Moretta. 1997. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186:1129.
19. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:2065.
20. Shibuya, A., D. Campbell, C. Hannum, H. Yssel, K. Franz-Bacon, T. McClanahan, T. Kitamura, J. Nicholl, G. R. Sutherland, L. L. Lanier, and J. H. Phillips. 1996. DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 4:573.
21. Chambers, B. J., M. Salcedo, and H.-G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5:311.
22. Renard, V., A. Cambiaggi, F. Vély, M. Blery, L. Olcese, S. Olivero, M. Bouchet, and E. Vivier. 1997. Transduction ot cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Immunol. Rev. 155:205.
23. Biassoni, R., C. Cantoni, M. Falco, S. Verdiani, C. Bottino, M. Vitale, R. Conte, A. Poggi, A. Moretta, and L. Moretta. 1996. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions. J. Exp. Med. 183:645.
24. Vély, F., and E. Vivier. 1997. Commentary: conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and non-inhibitory/activatory counterparts. J. Immunol. 159:2075.
25. Olcese, L., A. Cambiaggi, G. Semenzato, C. Bottino, A. Moretta, and E. Vivier. 1997. Killer-cell activatory receptors for MHC Class I molecules are included in a multimeric complex expressed by human killer cells. J. Immunol. 158:5083.
26. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703.
27. Tomasello, E., L. Olcese, F. Vély, C. Geourjon, M. Bléry, A Moqrich, G. Gautheret, M. Djabali, M. G. Mattei, and E. Vivier. 1998. Gene structure, expression pattern and biological activity of KAR-associated protein (KARAP)/DAP-12. J. Biol. Chem. 273:34115.
28. Mason, L. H., J. Willette-Brown, S. K. Anderson, P. Gosselin, E. W. Shores, P. E. Love, J. R. Ortaldo, and D. W. McVicar. 1998. Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J. Immunol. 160:4148.
29. Smith, K. M., J. Wu, A. B. H. Bakker, J. H. Phillips, and L. L. Lanier. 1998. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J. Immunol. 161:7.
30. Brumbaugh, K. M., B. A. Binstadt, D. D. Billadeau, R. A. Schoon, C. J. Dick, R. M. Ten, and P. J. Leibson. 1997. Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity. J. Exp. Med. 186:1965.
31. Bernard, K., N. Auphan, S. Granjeaud, G. Victorero, A. M. Schmitt-Verhulst, B. R. Jordan, and C. Nguyen. 1996. Multiplex messenger assay: simultaneous, quantitative measurement of expression of many genes in the context of T cell activation. Nucleic Acids Res. 24:1435.
32. Granjeaud, S., C. Nguyen, D. Rocha, R. Luton, and B. R. Jordan. 1996. From hybridization image to numerical values: a practical, high throughput quantification system for high density filter hybridizations. Genet. Anal. 12:151.
33. Nguyen, C., D. Rocha, S. Granjeaud, M. Baldit, K. Bernard, P. Naquet, and B. R. Jordan. 1995. Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones. Genomics 29:207.
34. Robertson, M. J., K. J. Cochran, C. Cameron, J. M. Le, R. Tantravathi, and J. Ritz. 1996. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24:406.
35. + lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory functions. Blood 87:2369.
36. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
37. Rocha, D., A. Carrier, M. Naspetti, G. Victorero, E. Anderson, M. Botcherby, J. L. Guénet, C. Nguyen, P. Naquet, and B. R. Jordan. 1997. Modulation of mRNA levels in the presence of thymocytes and genome mapping for a set of genes expressed in mouse thymic epithelial cells. Immunogenetics 46:142.
38. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6.
39. Simon, A. K., N. Auphan, and A. M. Schmitt-Verhulst. 1996. Developmental control of antigen-induced thymie transcription factors. Int. Immunol. 8:1421.
40. Colonna, M., F. Navarro, T. Bellon, M. Liano, P. Garcia, J. Samaridis, L. Angman, M. Cella, and M. Lopez-Botet. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186:1809.
41. Kaufman, D. S., R. A. Schoon, M. J. Robertson, and P. J. Leibson. 1995. Inhibition of selective signaling events in natural killer cells recognizing major histocompatibility complex class I. Proc. Natl. Acad. Sci. USA 92:6484.
42. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A. M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta. J. Exp. Med. 174:1393.
43. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129.
44. Trotta, R., P. Kanakaraj, and B. Perussia. 1996. FcγR-dependent mitogen-activated protein kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF-α and early activation genes. J. Med. 184:1027.
45. Valle Blazquez, M., I. Luque, E. Collantes, E. Aranda, R. Solana, J. Pena, and E. Munoz. 1997. Cellular redox status influences both cytotoxic and NF-κB activation in natural killer cells. Immunology 90:455.
46. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.
47. Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403.
48. Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1 : a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025.
49. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489.
50. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
51. Wei, S., A. M. Gamero, J. H. Liu, A. A. Daulton, N. I. Valkov, J. A. Trapani, A. C. Larner, M. J. Weber, and J. Y. Djeu. 1998. Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perform and granzyme B mobilization by functional ERK2. J. Exp. Med. 187:1753.
52. Coffer, P., M. de Jonge, A. Mettouchi, B. Binetruy, J. Ghysdael, and W. Kruijer. 1994. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2. Oncogene 9:911.
53. Kallunki, T., T. Deng, M. Hibi, and M. Karin. 1996. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell 87: 929.
54. Mondino, A., C. D. Whaley, D. R. DeSilva, W. Li, M. K. Jenkins, and D. L. Mueller. 1996. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157:2048.
55. Foletta, V. C., D. H. Segal, and D. R. Cohen. 1998. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukocyte Biol. 63:139.